We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HRL:NYSEHormel Foods Corporation Analysis

Data as of 2026-03-11 - not real-time

$23.13

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Hormel Foods (HRL) is trading at $23.13, just above the computed support level of $22.81 and well below the resistance of $26.22. The RSI of 38 and a bearish MACD histogram suggest the stock is nearing oversold conditions, while the neutral trend and decreasing volume point to limited short‑term upside. Valuation metrics are starkly misaligned: a trailing P/E of ~26 versus a forward P/E of 14.6 and a DCF‑derived fair value of $6.63 imply the market is pricing in significant premium, resulting in an overvalued label. Nonetheless, the dividend yield remains attractive at 5% despite a payout ratio above 100%, raising questions about sustainability.
Fundamentally, revenue grew modestly 1.3% YoY to $3.03 B in Q1, with EPS slightly below expectations, and the company reaffirmed FY‑26 guidance while divesting its turkey business to streamline the portfolio. The modest operating margins (7.4% operating, 4% net) and solid cash generation ($0.88 B operating cash flow) support a value‑oriented case, but the high dividend payout and volatile price action suggest caution for short‑term traders.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with bearish MACD
  • Decreasing volume indicating limited momentum
  • High dividend yield but unsustainable payout

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward P/E compression to 14.6 suggests valuation improvement
  • Stable cash flow and modest revenue growth
  • Portfolio simplification after turkey business divestiture

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Defensive consumer staples sector with low beta
  • Attractive dividend yield if payout ratio normalizes
  • Long‑term earnings visibility from branded food portfolio

Key Metrics & Analysis

Financial Health

Revenue Growth1.30%
Profit Margin4.03%
P/E Ratio26.0
ROE6.12%
ROA4.43%
Debt/Equity35.93
P/B Ratio1.6
Op. Cash Flow$885.3M
Free Cash Flow$381.5M

Technical Analysis

TrendNeutral
RSI38.0
Support$22.81
Resistance$26.22
MA 20$24.41
MA 50$24.24
MA 200$25.85
MACDBearish
VolumeDecreasing
Fear & Greed Index77.63

Valuation

Fair Value$6.63
Target Price$27.63
Upside/Downside19.46%
GradeOvervalued
TypeValue
Dividend Yield5.01%

Risk Assessment

Beta0.09
Volatility29.31%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.